Page results
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Latest news and developments in the Macmillan Support and Information Service
-
Information about staff who work in the Macmillan Support and Information Service.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
File results
-
FOI/2023/0370 - Trust’s total budget/ spend for inpatient food for 2018 - 2022
-
FOI/2023/0371 - Long Covid paediatric hub
-
FOI/2022/0266 - Drug Patient Level Contract Monitoring (DrPLCM)/ SACT cancer report
-
FOI/2023/0374 - Stillbirths, neonatal deaths, maternal deaths at Trust from 2018 - 2022
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0386 - Sickle Cell staffing and patients